ferumoxytol

This page shows the latest ferumoxytol news and features for those working in and with pharma, biotech and healthcare.

Amag buys into maternal health business

Adding Makena into its portfolio will give Amag an opportunity in future to increase sales of its own flagship product Feraheme (ferumoxytol), used to treat iron-deficiency anaemia in patients with

Latest news

Death leads to recall of batch of Takeda's Rienso in Switzerland

Marketing partner Amag also reports three other hypersensitivity reactions. Takeda has recalled a batch of its anaemia medicine Rienso (ferumoxytol) in Switzerland following four reports of hypersensitivity reactions, including one death.
SMC approves Eliquis, restricts use of Rienso

Meanwhile the SMC's latest round of decisions also saw it back the restricted use of Takeda's treatment for iron deficiency anaemia in chronic kidney disease (CKD) Rienso (ferumoxytol).
Orphan drug focus

318. AMAG Pharmaceuticals/ Takeda. feraheme (ferumoxytol) - for iron deficiency anaemia.
Takeda to cut 10 per cent of jobs

and Feraheme (ferumoxytol) for anaemia associated with chronic renal failure.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Interview: Trevor Smith, Takeda

iron deficiency anaemia treatment Rienso (ferumoxytol) in June.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Spectrum appoints chief medical officer

2013. The appointment is a return to oncology for Dr Allen following a six-year spell as chief medical officer at AMAG Pharmaceuticals – the developer of Feraheme (ferumoxytol) for the treatment

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Events Executive: DOE

Senior Medical Writer: Competitive salary plus benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Manager – Healthcare advertising: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Client Services Director- Flexible Working: Negotiable

Account Director – UK Office: Excellent salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...